| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $13K | -26.0% |
| SG&A Expense | $60K | +68.2% |
| Operating Income | -$985K | -192.3% |
| Pre-tax Income | -$985K | -315.7% |
| Net Income | -$985K | -315.7% |
| EPS (Basic) | -$0.03 | -200.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14K | -93.5% |
| Current Assets | $72K | -67.7% |
| Total Assets | $72K | -87.9% |
| Current Liabilities | $1.0M | +42.9% |
| Stockholders' Equity | -$951K | -681.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$238K | +46.3% |
| Investing Cash Flow | $100K | +0.0% |
| Financing Cash Flow | $35K | -93.8% |